PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Wed, 03/08/2017 - 10:21
#1
Jim Galasso
Offline
Last seen: 1 month 1 week ago
Joined: 11/03/2015 - 12:17
Methotrexate Issues
Our Pediatric Hematology Oncology Physician has noticed a toxicity pattern with our leukemia patients receiving high dose methotrexate. It seems that the patients have had delayed clearance and more severe myelosuppression than usual. She feels that it could be related to the product we purchase. We currently purchase methotrexate manufactured from Accord/Hospira and Teva. The manufacturers haven't had any recalls to date. I was wondering if anyone in our MSOS group, who purchases methotrexate from these manufacturers, have noticed the same patterns.
Thank you for your help.
